SCHEMBL14021278

SCHEMBL14021278

CC(=O)NCCSc1ccc(-c2ccnc(Nc3ccc(C(=O)N4CCN[C@H](C)C4)cc3)n2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IKBKB O14920 3/20 0.46
▸ CHUK O15111 3/20 0.46
▸ JAK2 O60674 14/20 0.42
▸ JAK3 P52333 11/20 0.41
▸ JAK1 P23458 8/20 0.41
▸ CDK2 P24941 2/20 0.41
▸ BMPR1B O00238 1/20 0.41
▸ PLK4 O00444 1/20 0.41
▸ CIT O14578 1/20 0.41
▸ GAK O14976 1/20 0.41
▸ OPA1 O60313 1/20 0.41
▸ ROCK2 O75116 1/20 0.41
▸ STK16 O75716 1/20 0.41
▸ PRKD3 O94806 1/20 0.41
▸ CSNK2A2 P19784 1/20 0.41
▸ MARK3 P27448 1/20 0.41
▸ TYK2 P29597 1/20 0.41
▸ BMPR1A P36894 1/20 0.41
▸ TGFBR1 P36897 1/20 0.41
▸ STAT3 P40763 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8312437 0.88 IKBKB (0.47) IKBKBCHUKJAK2JAK3JAK1
SCHEMBL8249628 0.87 IKBKB (0.47) IKBKBCHUKJAK2JAK3JAK1
SCHEMBL8308477 0.86 IKBKB (0.46) IKBKBCHUKJAK2JAK3JAK1
SCHEMBL14021279 0.86 JAK2 (0.48) IKBKBCHUKJAK2JAK3JAK1
SCHEMBL8312120 0.85 JAK2 (0.45) IKBKBCHUKJAK2JAK3JAK1
SCHEMBL14021276 0.83 IKBKB (0.55) IKBKBCHUKJAK2JAK3JAK1
SCHEMBL14021274 0.83 IKBKB (0.55) IKBKBCHUKJAK2JAK3JAK1
SCHEMBL14021271 0.83 IKBKB (0.55) IKBKBCHUKJAK2JAK3JAK1
SCHEMBL14063856 0.80 IKBKB (0.53) IKBKBCHUKJAK2
SCHEMBL8312555 0.79 IKBKB (0.52) IKBKBCHUK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7442699-B2 Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto SIGNAL PHARMACEUTICALS, LLC (US) 2008-10-28 — — US disclosed
US-7442699-B2 Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto SIGNAL PHARMACEUTICALS, LLC (US) 2008-10-28 — — US disclosed
US-7429599-B2 Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK SIGNAL PHARMACEUTICALS, LLC (US) 2008-09-30 — — US disclosed
US-7429599-B2 Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK SIGNAL PHARMACEUTICALS, LLC (US) 2008-09-30 — — US disclosed
Send feedback